Display options
Share it on

J Basic Clin Pharm. 2014 Dec;6(1):1-6. doi: 10.4103/0976-0105.145759.

Quality of prescribing for hypertension and bronchial asthma at a tertiary health care facility, India using Prescription Quality Index tool.

Journal of basic and clinical pharmacy

Jalpa V Suthar, Varsha J Patel, B Vaishnav

Affiliations

  1. Department of Pharmacology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Gujarat, India.
  2. Department of Pharmacology, NHL Municipal Medical College, Ahmedabad, Gujarat, India.
  3. Department of Medicine, Shree Krishna Hospital, Karamsad, Gujarat, India.

PMID: 25538464 PMCID: PMC4268623 DOI: 10.4103/0976-0105.145759

Abstract

OBJECTIVE: Several tools have been introduced to evaluate the quality of prescribing. The aim of this study was to determine the quality of prescribing in hypertension and bronchial asthma in tertiary health care (THC) setting using the new Prescription Quality Index (PQI) tool and to assess the reliability of this tool.

METHODS: A prospective cross-sectional study was carried out for 2 months in order to assess the quality of prescribing of antihypertensive and antiasthmatic drugs using recently described PQI at THC facility. Patients with hypertension and bronchial asthma, attending out-patient departments of internal medicine and pulmonary medicine respectively for at least 3 months were included. Complete medical history and prescriptions received were noted. Total and criteria wise PQI scores were derived for each prescription. Prescriptions were categorized as poor, medium and high quality based on total PQI scores.

RESULTS: A total of 222 patients were included. Mean age was 56 ± 15.1 years (range 4-87 years) with 67 (30.2%) patients above 65 years of age. Mean total PQI score was 32.1 ± 5.1. Of 222 prescriptions, 103 (46.4%) prescriptions were of high quality with PQI score ≥34. Quality of prescribing did not differ between hypertension and bronchial asthma (P > 0.05). The value of Cronbach's α for the entire 22 criteria of PQI was 0.71.

CONCLUSION: As evaluated by PQI tool, the quality of prescribing for hypertension and bronchial asthma is good in about 47% of prescriptions at THC facility. PQI is valid for measuring prescribing quality in these chronic diseases in Indian setting.

Keywords: Bronchial asthma; Prescription Quality Index tool; hypertension; prescribing quality; rational prescribing

References

  1. J Am Geriatr Soc. 2006 Oct;54(10):1516-23 - PubMed
  2. JAMA. 2003 Sep 17;290(11):1494-9 - PubMed
  3. J Nurs Scholarsh. 2007;39(2):155-64 - PubMed
  4. Arch Intern Med. 1991 Sep;151(9):1825-32 - PubMed
  5. Br J Clin Pharmacol. 2010 Oct;70(4):500-13 - PubMed
  6. Fam Pract. 2004 Oct;21(5):575-81 - PubMed
  7. Arch Intern Med. 2003 Dec 8-22;163(22):2716-24 - PubMed
  8. Fam Pract. 2001 Oct;18(5):528-33 - PubMed
  9. BMC Health Serv Res. 2013 May 07;13:170 - PubMed
  10. Scand J Prim Health Care. 2003 Mar;21(1):47-51 - PubMed
  11. JAMA. 2005 Mar 16;293(11):1348-58 - PubMed
  12. Arch Intern Med. 1997 Jul 28;157(14):1531-6 - PubMed
  13. Eur J Clin Pharmacol. 1998 May;54(3):197-202 - PubMed
  14. Qual Saf Health Care. 2003 Jun;12(3):176-80 - PubMed
  15. Eur J Clin Pharmacol. 2006 Nov;62(11):953-8 - PubMed
  16. Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):314-9 - PubMed
  17. J Clin Epidemiol. 1992 Oct;45(10):1045-51 - PubMed
  18. J Am Med Inform Assoc. 2008 Sep-Oct;15(5):585-600 - PubMed
  19. JAMA. 1999 Jul 14;282(2):113-5 - PubMed
  20. JAMA. 2001 Dec 12;286(22):2823-9 - PubMed
  21. Med Care. 1999 Dec;37(12):1294-307 - PubMed

Publication Types